Peptonic Medical Stock Book Value Per Share
| 28L Stock | 0.0002 0.00 0.00% |
PEPTONIC MEDICAL fundamentals help investors to digest information that contributes to PEPTONIC MEDICAL's financial success or failures. It also enables traders to predict the movement of PEPTONIC Stock. The fundamental analysis module provides a way to measure PEPTONIC MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PEPTONIC MEDICAL stock.
PEPTONIC |
PEPTONIC MEDICAL Company Book Value Per Share Analysis
PEPTONIC MEDICAL's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current PEPTONIC MEDICAL Book Value Per Share | 0.72 X |
Most of PEPTONIC MEDICAL's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PEPTONIC MEDICAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of PEPTONIC MEDICAL is about 0.723 times. This is much higher than that of the sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The book value per share for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
PEPTONIC Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (1.88) % | |||
| Shares Outstanding | 396.79 M | |||
| Gross Profit | 19.07 M | |||
| Book Value Per Share | 0.72 X | |||
| Earnings Per Share | (0.19) X | |||
| Beta | 0.58 | |||
| Market Capitalization | 3.77 M |
About PEPTONIC MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PEPTONIC MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PEPTONIC MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PEPTONIC MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PEPTONIC Stock
PEPTONIC MEDICAL financial ratios help investors to determine whether PEPTONIC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PEPTONIC with respect to the benefits of owning PEPTONIC MEDICAL security.